These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11701975)

  • 1. Prognostic value of tyrosinase reverse-transcriptase polymerase chain reaction in metastatic melanoma.
    Quereux G; Denis M; Khammari A; Lustenberger P; Dreno B
    Dermatology; 2001; 203(3):221-5. PubMed ID: 11701975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma.
    Visús C; Andres R; Mayordomo JI; Martinez-Lorenzo MJ; Murillo L; Sáez-Gutiérrez B; Diestre C; Marcos I; Astier P; Godino J; Carapeto-Marquez de Prado FJ; Larrad L; Tres A
    Melanoma Res; 2007 Apr; 17(2):83-9. PubMed ID: 17496783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification of MelanA messenger RNA in addition to tyrosinase increases sensitivity of melanoma cell detection in peripheral blood and is associated with the clinical stage and prognosis of malignant melanoma.
    Schittek B; Bodingbauer Y; Ellwanger U; Blaheta HJ; Garbe C
    Br J Dermatol; 1999 Jul; 141(1):30-6. PubMed ID: 10417512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction.
    Palmieri G; Ascierto PA; Perrone F; Satriano SM; Ottaiano A; Daponte A; Napolitano M; Caracò C; Mozzillo N; Melucci MT; Cossu A; Tanda F; Gallo C; Satriano RA; Castello G
    J Clin Oncol; 2003 Mar; 21(5):767-73. PubMed ID: 12610172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma.
    Kunter U; Buer J; Probst M; Duensing S; Dallmann I; Grosse J; Kirchner H; Schluepen EM; Volkenandt M; Ganser A; Atzpodien J
    J Natl Cancer Inst; 1996 May; 88(9):590-4. PubMed ID: 8609659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis.
    Mellado B; Colomer D; Castel T; Muñoz M; Carballo E; Galán M; Mascaró JM; Vives-Corrons JL; Grau JJ; Estapé J
    J Clin Oncol; 1996 Jul; 14(7):2091-7. PubMed ID: 8683241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of tyrosinase mRNA detected by nested RT-PCR in patients with malignant melanoma.
    Glumac N; Snoj M; Hocevar M; Novakovic S
    Neoplasma; 2006; 53(1):9-14. PubMed ID: 16416006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facts and pitfalls in the detection of tyrosinase mRNA in the blood of melanoma patients by RT-PCR.
    Seiter S; Rappl G; Tilgen W; Ugurel S; Reinhold U
    Recent Results Cancer Res; 2001; 158():105-12. PubMed ID: 11092037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
    Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
    Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RT-PCR for tyrosinase-mRNA-positive cells in peripheral blood: evaluation strategy and correlation with known prognostic markers in 123 melanoma patients.
    Farthmann B; Eberle J; Krasagakis K; Gstöttner M; Wang N; Bisson S; Orfanos CE
    J Invest Dermatol; 1998 Mar; 110(3):263-7. PubMed ID: 9506446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of reverse transcriptase-polymerase chain reaction for tyrosinase mRNA as a marker for circulating tumor cells in cutaneous melanoma.
    Tsao H; Nadiminti U; Sober AJ; Bigby M
    Arch Dermatol; 2001 Mar; 137(3):325-30. PubMed ID: 11255333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of the sequential detection of circulating melanoma cells by RT-PCR in high-risk melanoma patients receiving adjuvant interferon.
    Gogas H; Kefala G; Bafaloukos D; Frangia K; Polyzos A; Pectasides D; Tsoutsos D; Panagiotou P; Ioannovich J; Loukopoulos D
    Br J Cancer; 2002 Jul; 87(2):181-6. PubMed ID: 12107840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of positive RT-PCR for tyrosinase in peripheral blood of malignant melanoma patients with clinical stage, survival and other risk factors.
    Proebstle TM; Jiang W; Högel J; Keilholz U; Weber L; Voit C
    Br J Cancer; 2000 Jan; 82(1):118-23. PubMed ID: 10638977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased sensitivity for the detection of malignant melanoma cells in peripheral blood using an improved protocol for reverse transcription-polymerase chain reaction.
    Schittek B; Blaheta HJ; Flörchinger G; Sauer B; Garbe C
    Br J Dermatol; 1999 Jul; 141(1):37-43. PubMed ID: 10417513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance and diagnostic value of protein S-100 and tyrosinase in patients with malignant melanoma.
    Andrés R; Mayordomo JI; Visus C; Isla D; Godino J; Escudero P; Saenz A; Ortega E; Lastra R; Lambea J; Aguirre E; Elosegui L; Marcos I; Ruiz-Echarri M; Millastre E; Sáez-Gutierrez B; Asin L; Vidal MJ; Ferrer A; Giner A; Larrad L; Carapeto FJ; Tres A
    Am J Clin Oncol; 2008 Aug; 31(4):335-9. PubMed ID: 18845991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverse transcriptase-polymerase chain reaction detection of circulating tumor cells in patients with melanoma: correlation with clinical stage, tumor thickness and histological type.
    Carrillo E; Prados J; Melguizo C; Marchal JA; Vélez C; Serrano S; Boulaiz H; Mérida JA; Aránega A
    Pathol Int; 2002 Apr; 52(4):294-9. PubMed ID: 12031085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detection of tyrosinase mRNA in the peripheral blood of stage I melanoma patients is not of clinical relevance in predicting metastasis risk and survival.
    Aubin F; Chtourou M; Teyssier JR; Laubriet A; Mougin CH; Blanc D; Humbert P
    Melanoma Res; 2000 Apr; 10(2):113-8. PubMed ID: 10803711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of circulating malignant cells by RT-PCR in long-term clinically disease-free I stage melanoma patients.
    Baldi A; Dragonetti E; Battista T; Groeger AM; Esposito V; Baldi G; Santini D
    Anticancer Res; 2000; 20(5C):3923-8. PubMed ID: 11268478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression. Melanoma Cooperative Group.
    Palmieri G; Strazzullo M; Ascierto PA; Satriano SM; Daponte A; Castello G
    J Clin Oncol; 1999 Jan; 17(1):304-11. PubMed ID: 10458247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimarker real-time reverse transcription-PCR for quantitative detection of melanoma-associated antigens: a novel possible staging method.
    Arenberger P; Arenbergerova M; Gkalpakiotis S; Lippert J; Stribrna J; Kremen J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):56-64. PubMed ID: 18181974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.